T1	Condition 79 102	high risk blood disease
T2	Condition 106 112	cancer
*	OR T1 T2
T3	Measurement 140 165	Estimated life expectancy
T4	Value 169 207	at least 6 weeks following study entry
R1	Has_value Arg1:T3 Arg2:T4	
T5	Measurement 209 263	Cancer and Leukemia Group B (CALGB) performance status
T8	Value 264 287	less than or equal to 2
T9	Measurement 289 311	White blood cell count
T10	Measurement 313 321	platelet
T11	Measurement 323 333	hematocrit
T12	Measurement 335 347	tuberculosis
T13	Measurement 349 381	aspartate aminotransferase (AST)
R2	Has_value Arg1:T5 Arg2:T8	
T6	Measurement 383 413	alanine aminotransferase (ALT)
T7	Measurement 415 435	alkaline phosphatase
T14	Measurement 437 447	creatinine
T15	Measurement 453 469	HIV test results
T16	Qualifier 470 499	reviewed by transplant center
T17	Scope 289 469	White blood cell count, platelet, hematocrit, tuberculosis, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, creatinine, and HIV test results
R3	Has_qualifier Arg1:T17 Arg2:T16	
T18	Procedure 501 534	Multiple gated acquisition (MUGA)
T19	Procedure 536 550	echocardiogram
T20	Procedure 552 563	cardiac MRI
T21	Procedure 572 602	pulmonary function tests (PFT)
*	OR T18 T19 T20 T21
T22	Qualifier 617 646	reviewed by transplant center
T23	Scope 501 602	Multiple gated acquisition (MUGA), echocardiogram, cardiac MRI, and/or pulmonary function tests (PFT)
R4	Has_qualifier Arg1:T23 Arg2:T22	
T24	Person 970 976	female
A1	Optional T24
T25	Procedure 993 1006	contraception
R5	AND Arg1:T24 Arg2:T25	
T26	Temporal 1007 1027	throughout the study
R6	Has_temporal Arg1:T25 Arg2:T26	
T27	Measurement 909 945	umbilical cord blood units available
T28	Value 888 905	Sufficient number
R7	Has_value Arg1:T27 Arg2:T28	
T29	Qualifier 946 965	for transplantation
T30	Procedure 950 965	transplantation
R8	multi Arg1:T29 Arg2:T30	
R9	Has_qualifier Arg1:T27 Arg2:T29	
